Drug therapy during cardiopulmonary resuscitation;Medikamentöse therapie bei der kardiopulmonalen reanimation

Wiener Klinische Wochenschrift

Volumn 113, Issue 23-24, 2001, Pages 915-926

  Wenzel, V ^a   Krismer, A C ^a   Mayr, V D ^a   Voelckel, W G ^a   Strohmenger, H U ^a   Lindner, K H ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Amiodarone; Atropine; Calcium; Cardiopulmonary resuscitation; Endobronchial drug administration; Endothelin; Epinephrine; Guidelines; Intraosseous injection; Postresuscitation phase; Sodium bicarbonate; Vasopressin

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; ARGIPRESSIN; ATROPINE; BICARBONATE; CALCIUM; CORTICOTROPIN; ENDOTHELIN 1; HYDROCORTISONE; VASOPRESSIN;

ACID BASE BALANCE; ASYSTOLE; HEART VENTRICLE FIBRILLATION; HUMAN; PRACTICE GUIDELINE; RESUSCITATION; REVIEW; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY RESUSCITATION; CARDIOTONIC AGENTS; DRUG ADMINISTRATION ROUTES; EVIDENCE-BASED MEDICINE; HEART ARREST; HUMANS; PRACTICE GUIDELINES; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 17544393374     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. CPR challenges in pediatrics
2. Austrian emergency medicine in an international comparison
3. Oops! EMS mistakes - They're inevitable, stressful, painful and oh-so educational. This guide helps you classify them and avoid sweating the small stuff
4. Physician compliance with advanced cardiac life support guidelines
5. Complications of routine intensive care interventions
6. A comparison of standard cardiopulmonary resuscitation and active compression-decompression resuscitation for out-of-hospital cardiac arrest
7. Prognosis for cardiopulmonary resuscitation
8. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation
9. Standards for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC)
10. Standards and guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC)
11. Standards and guidelines for cardiopulmonary resuscitation (CPR), and emergency cardiac care (ECC)
12. Guidelines for cardiopulmonary resuscitation and emergency cardiac care
13. Guidelines for advanced life support: A statement by the advanced life support working party of the European Resuscitation Council
14. Guidelines for basic and advanced management of the airway and ventilation during resuscitation
15. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. International consensus on science
16. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. International consensus on science
17. Endotracheal administration of epinephrine during cardiopulmonary resuscitation
18. Endobronchial administration of emergency drugs
19. The difficult airway
20. Endotracheal and endobronchial lidocaine administration: Effects on plasma lidocaine concentration and blood gases
21. Pharmacokinetics and technique of endotracheal and deep endobronchial lidocaine administration
22. Endotracheal versus intravenous epinephrine during electromechanical dissociation with CPR in dogs
23. Endobronchial drug administration: Does deep endobronchial delivery have advantages in comparison with simple injection through the endotracheal tube?
24. 2 with endobronchial administration: Dilution with normal saline or distilled water?
25. What is the optimal volume of administration for endobronchial drugs?
26. The 1998 European Resuscitation Council guidelines for adult advanced life support: A statement from the Working Group on Advanced Life Support, and approved by the executive committee
27. Cardiopulmonary resuscitation by chest compression alone or with mouth-to-mouth ventilation
28. International Guidelines 2000 for CPR and ECC. A consensus on science. Part 10: Pediatric advanced life support
29. A strategy to improve endobronchial drug administration
30. International Guidelines for CPR and ECC. A consensus on science. Part 6: Advanced cardiovascular life support. Section Pharmacology II: Agents to optimize cardiac output and blood pressure
31. Comparison of the pharmacological effects of epinephrine administered by the intravenous and endotracheal routes
32. Intraosseous infusions: A flexible option for the adult or child with delayed, difficult, or impossible conventional vascular access
33. Infusions of blood an other fluids via the bone marrow
34. Intraosseous infusion
35. Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs
36. Intraosseus vasopressin improves coronary perfusion pressure rapidly during cardiopulmonary resuscitation in pigs
37. The current status of intraosseous infusion
38. Über die wirkung der nebennierenextrakte auf Herz und Blutdruck
39. An experimental research into resuscitation of dogs killed by anaesthetics and asphyxia
40. The choice of vasopressor agents in cardiopulmonary resuscitation
41. Epinephrine in cardiac arrest: A critical review
42. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs
43. Postcountershock pulseless rhythms. Response to CPR, artificial cardiac pacing, and adrenergic agonists
44. Epinephrine increases the severity of postresuscitation myocardial dysfunction
45. Epinephrine facilitates cardiac fibrillation by shortening action potential refractoriness
46. High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest
47. Randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest
48. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital
49. High-dose epinephrine in adult cardiac arrest
50. Cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome
51. Plasma catecholamine concentrations after successful resuscitation in patients
52. Hemodynamic and metabolic effects of epinephrine during cardiopulmonary resuscitation in a pig model
53. A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest
54. Stress hormone response during and after CPR
55. Release of endogenous vasopressors during and after cardiopulmonary resuscitation
56. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs
57. Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs
58. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs
59. Vasopressin combined with epinephrine decreases cerebral perfusion compared with vasopressin alone during cardiopulmonary resuscitation in pigs
60. Effects of vasopressin and epinephrine on splanchnic blood flow and renal function during and after cardiopulmonary resuscitation in pigs
61. Vasopressin decreases endogenous catecholamine plasma levels during cardiopulmonary resuscitation in pigs
62. Effect of small-dose dopamine on mesenteric blood flow and renal function in a pig model of cardiopulmonary resuscitation with vasopressin
63. Endobronchial vasopressin improves survival during cardiopulmonary resuscitation in pigs
64. Repeated administration of vasopressin, but not epinephrine, maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs
65. Survival with full neurological recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs
66. Vasopressin administration in refractory cardiac arrest
67. A randomized comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation
68. Vasopressin can improve coronary perfusion pressure during human cardiopulmonary resus citation
69. Vasopressin versus epinephrine for inhospital cardiac arrest: A randomised controlled trial
70. The effects of endothelin-1 on coronary perfusion pressure during CPR in a canine model
71. Endothelin-1 vasoconstriction during swine cardiopulmonary resuscitation improves coronary perfusion pressures but worsens postresuscitation outcome
72. Role of endothelin-1 in the failure of cerebral circulation after complete global cerebral ischemia
73. Prehospital brady-asystolic cardiac arrest
74. Use of atropine for brady-asystolic prehospital cardiac arrest
75. Standard and higher doses of atropine in a canine model of pulseless electrical activity
76. Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation
77. Failure of sodium bicarbonate to improve resuscitation from ventricular fibrillation in dogs
78. Buffer solutions may compromise cardiac resuscitation by reducing coronary perfusion pressure
79. The use of antiarrhythmics in advanced cardiac life support
80. Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients
81. Metaanalytic evidence against prophylactic use of lidocaine in acute myocardial infarction
82. Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival?
83. International guidelines for CPR ECC. A consensus on science. Advanced cardiac life support Section 5: Pharmacology I: Agents for arrythmias
84. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest?
85. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation
86. Doseranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias
87. Endocardial and transcutaneous cardiac pacing, calcium chloride, and epinephrine in postcountershock asystole and bradycardias
88. Calcium chloride in experimental electromechanical dissociation: A placebo-controlled trial in dogs
89. Post-ischaemic organ dysfunction: A review
90. Impairment of renal function in patients resuscitated from cardiac arrest: Frequency, determinants and impact on outcome
91. Postresuscitation management
92. Five hundred patients with myocardial infarction monitored within one hour of symptoms
93. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial
94. Acute renal failure and rhabdomyolosis after inadvertent intra-arterial infusion of excessive doses of epinephrine during cardiopulmonary resuscitation
95. Mild cerebral hypothermia during and after cardiac arrest improves neurological outcome in dogs
96. Mild resuscitative hypothermia to improve neurological outcome after cardiac arrest. A clinical feasibility trial
97. Thiopental combination treatments for cerebral resuscitation after prolonged cardiac arrest in dogs. Exploratory outcome study
98. Cerebral resuscitation from cardiac arrest: Treatment potentials
99. Glucocorticoid treatment does not improve neurological recovery following cardiac arrest. Brain resuscitation
100. Acute renal failure and rhabdomyolosis after inadvertent intra-arterial infusion of excessive doses of epinephrine during cardiopulmonary resuscitation
101. History of cardiopulmonary-cerebral resuscitation
102. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion
103. Molecular and metabolic aspects of mammalian hibernation